Michael A. Berman, Director at CADENCE PHARMACEUTICALS INC (CADX), bought 8,500 shares at $9.45 ($102K) on 2006-11-01, disclosed to the SEC on 2007-05-11.
Open-market purchase of $102k CADX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.45 | 1,000 | $9K | 9.3% |
| 2 | $12.50 | 2,500 | $31K | 30.8% |
| 3 | $12.17 | 5,000 | $61K | 59.9% |
| Total | $11.95 avg | 8,500 | $102K | 100% |
| Filing → |
| MDC | SELL | 2019-09-17 | $290K | — | Filing → |
| MDC | SELL | 2019-09-16 | $408K | — | Filing → |
| MDC | SELL | 2019-09-12 | $391K | — | Filing → |